Compare Fluor Corporation Common Stock (FLR) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fluor Corporation Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Fluor Corporation Common Stock trades at $50.59 (market cap $6.82B), while Halozyme Therapeutics Inc. Common Stock trades at $111.12 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Fluor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fluor Corporation Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| FLR | HALO | |
|---|---|---|
Market Cap | $6.82B | $12.58B |
Volume | 1,748,454 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $57.50 | $115.22 |
52-Week Low | $39.63 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $4.85B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fluor Corporation Common Stock
Fluor provides engineering, procurement, construction, and maintenance services. It works across energy, infrastructure, mining, advanced technology, manufacturing, life sciences, and government projects.
Read more on FLR →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
